These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 6200058
1. Central nervous system catecholamine metabolism in Korsakoff's psychosis. Martin PR, Weingartner H, Gordon EK, Burns RS, Linnoila M, Kopin IJ, Ebert MH. Ann Neurol; 1984 Feb; 15(2):184-7. PubMed ID: 6200058 [Abstract] [Full Text] [Related]
2. Memory impairment in Korsakoff's psychosis: a correlation with brain noradrenergic activity. McEntee WJ, Mair RG. Science; 1978 Nov 24; 202(4370):905-7. PubMed ID: 715450 [Abstract] [Full Text] [Related]
3. Monoamine activity correlates with psychometric deficits in Korsakoff's disease. Mair RG, McEntee WJ, Zatorre RJ. Behav Brain Res; 1985 May 24; 15(3):247-54. PubMed ID: 2408635 [Abstract] [Full Text] [Related]
5. Cerebrospinal fluid monoamine metabolites during alcohol withdrawal syndrome and recovered state. Fujimoto A, Nagao T, Ebara T, Sato M, Otsuki S. Biol Psychiatry; 1983 Oct 24; 18(10):1141-52. PubMed ID: 6197099 [Abstract] [Full Text] [Related]
6. Neurochemical specificity of learning: dopamine and motor learning. McEntee WJ, Mair RG, Langlais PJ. Yale J Biol Med; 1987 Oct 24; 60(2):187-93. PubMed ID: 2437709 [Abstract] [Full Text] [Related]
7. Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome. Kay AD, Schapiro MB, Riker AK, Haxby JV, Rapoport SI, Cutler NR. Ann Neurol; 1987 Apr 24; 21(4):408-11. PubMed ID: 2437853 [Abstract] [Full Text] [Related]
8. Multimodal sensory discrimination deficits in Korsakoff's psychosis. Mair RG, Doty RL, Kelly KM, Wilson CS, Langlais PJ, McEntee WJ, Vollmecke TA. Neuropsychologia; 1986 Apr 24; 24(6):831-9. PubMed ID: 2433640 [Abstract] [Full Text] [Related]
10. Reduced concentrations of arginine vasopressin and MHPG in lumbar CSF of patients with Korsakoff's psychosis. Mair RG, Langlais PJ, Mazurek MF, Beal MF, Martin JB, McEntee WJ. Life Sci; 1986 Jun 23; 38(25):2301-6. PubMed ID: 2425205 [Abstract] [Full Text] [Related]
11. Monoamine metabolites in normal human cerebrospinal fluid and in degenerative diseases of the central nervous system. González-Quevedo A, García JC, Fernández R, Fernández Cartaya L. Bol Estud Med Biol; 1993 Jun 23; 41(1-4):13-9. PubMed ID: 7521168 [Abstract] [Full Text] [Related]
12. Effects of clonidine on central and peripheral catecholamine metabolism. Martin PR, Ebert MH, Gordon EK, Linnoila M, Kopin IJ. Clin Pharmacol Ther; 1984 Mar 23; 35(3):322-7. PubMed ID: 6199153 [Abstract] [Full Text] [Related]
13. Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in the pediatric opsoclonus-myoclonus syndrome. Pranzatelli MR, Huang Y, Tate E, Stanley M, Noetzel MJ, Gospe SM, Banasiak K. Ann Neurol; 1995 Feb 23; 37(2):189-97. PubMed ID: 7531417 [Abstract] [Full Text] [Related]
15. Monoamine precursors, transmitters and metabolites in cerebrospinal fluid: a prospective study in healthy male subjects. Eklundh T, Eriksson M, Sjöberg S, Nordin C. J Psychiatr Res; 1996 Feb 23; 30(3):201-8. PubMed ID: 8884658 [Abstract] [Full Text] [Related]
16. Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia. Faull KF, Guilleminault C, Berger PA, Barchas JD. Ann Neurol; 1983 Mar 23; 13(3):258-63. PubMed ID: 6189447 [Abstract] [Full Text] [Related]
18. CSF monoamine metabolite and beta endorphin levels in recently detoxified alcoholics and healthy controls: prediction of alcohol cue-induced craving? Petrakis IL, Trevisan L, D'Souza C, Gil R, Krasnicki S, Webb E, Heninger G, Cooney N, Krystal JH. Alcohol Clin Exp Res; 1999 Aug 23; 23(8):1336-41. PubMed ID: 10470976 [Abstract] [Full Text] [Related]
19. Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters. Jankovic J, Caskey TC, Stout JT, Butler IJ. Ann Neurol; 1988 May 23; 23(5):466-9. PubMed ID: 2455472 [Abstract] [Full Text] [Related]
20. A prospective study of the association of cerebrospinal fluid monoamine metabolite levels with lethality of suicide attempts in patients with bipolar disorder. Sher L, Carballo JJ, Grunebaum MF, Burke AK, Zalsman G, Huang YY, Mann JJ, Oquendo MA. Bipolar Disord; 2006 Oct 23; 8(5 Pt 2):543-50. PubMed ID: 17042827 [Abstract] [Full Text] [Related] Page: [Next] [New Search]